UPDATE: Goldman Sachs Starts Neogenomics (NEO) at Buy
Tweet Send to a Friend
(Updated - June 3, 2021 4:40 AM EDT)
Goldman Sachs analyst Matthew Sykes initiates coverage on Neogenomics (NASDAQ: NEO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Matthew Sykes initiates coverage on Neogenomics (NASDAQ: NEO) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
